Monte Rosa Therapeutics, Inc.

GLUE

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001826457

SEC filings (opens in a new tab)

In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of GLUE: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Q2 2025	Change
Holders	106	116	+10
Shares	59.5M	62.2M	+2.69M (+4.5%)
Value	$276.2M	$280.6M	+$4.38M (+1.6%)

New holders (27)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to GLUE in Q2 2025
Institution	Shares	Value	% of portfolio
Bridgeway Capital Management, LLC	271,400	$1.22M	0.03%
Squarepoint Ops LLC	178,136	$803.4K	0.00%
Citadel Advisors LLC	77,918	$351.4K	0.00%
Mackenzie Financial Corp	77,635	$350.1K	0.00%
Ieq Capital, LLC	73,975	$333.6K	0.00%
Two Sigma Advisers, LP	72,500	$327.0K	0.00%
Hillsdale Investment Management Inc.	60,100	$271.1K	0.01%
XTX Topco Ltd	54,440	$245.5K	0.01%
Man Group plc	36,391	$164.1K	0.00%
Integrated Quantitative Investments LLC	35,400	$159.7K	0.05%
Stonepine Capital Management, LLC	30,000	$135.3K	0.13%
Bailard, Inc.	22,500	$101.5K	0.00%
Sherbrooke Park Advisers LLC	21,867	$98.6K	0.04%
Wealth Enhancement Advisory Services, LLC	20,007	$97.4K	0.00%
Los Angeles Capital Management LLC	19,787	$89.2K	0.00%
Quantinno Capital Management LP	16,793	$75.7K	0.00%
Mariner, LLC	14,859	$67.0K	0.00%
Pallas Capital Advisors LLC	13,182	$59.5K	0.00%
Essential Partners LLC	13,002	$58.6K	0.02%
Prudential Financial Inc	12,054	$54.4K	0.00%
Brighton Jones LLC	10,559	$47.6K	0.00%
Royce & Associates LP	10,176	$45.9K	0.00%
Raymond James Financial Inc	1,200	$5.41K	0.00%
Caitong International Asset Management Co., Ltd	1,066	$4.81K	0.00%
Allworth Financial LP	482	$2.17K	0.00%
Skopos Labs, Inc.	92	$415	0.00%
Clearstead Advisors, LLC	25	$113	0.00%

Sold out (17)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of GLUE in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Readystate Asset Management LP	287,000	$1.33M
Ikarian Capital, LLC	136,575	$633.7K
Verition Fund Management LLC	51,725	$240.0K
Boothbay Fund Management, LLC	35,152	$163.1K
Graham Capital Management, L.P.	32,586	$151.2K
Corton Capital Inc.	29,348	$136.2K
Fox Run Management, L.L.C.	27,394	$127.1K
Trexquant Investment LP	26,188	$121.5K
Corebridge Financial, Inc.	20,233	$93.9K
Exchange Traded Concepts, LLC	18,928	$87.8K
TownSquare Capital, LLC	11,391	$52.9K
Simplex Trading, LLC	6,756	$31.0K
Group One Trading, L.P.	5,398	$25.0K
Coldstream Capital Management Inc	355	$1.65K
Northwestern Mutual Wealth Management Co	300	$1.39K
Parkside Financial Bank & Trust	95	$441
SRS Capital Advisors, Inc.	95	$441